Scientific Integrity and Mainstream Science

In legalese, the words that distinguish good science from bad are "mainstream" or "generally accepted." This is about as far as the law can go. This standard places a serious responsibility on the scientific community to ensure that mainstream science is indeed good science. Institutions are scrambling to develop means to monitor and deal with departures from proper scientific practices. Science reported1 that in Europe "a rising tide of retracted papers and some high-profile fraud cases

Written byTheodore Rockwell
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

In legalese, the words that distinguish good science from bad are "mainstream" or "generally accepted." This is about as far as the law can go. This standard places a serious responsibility on the scientific community to ensure that mainstream science is indeed good science.

Institutions are scrambling to develop means to monitor and deal with departures from proper scientific practices. Science reported1 that in Europe "a rising tide of retracted papers and some high-profile fraud cases are finally stirring research groups into action ... the very structure of research institutions might be creating an environment that encourages research misconduct." The American Association for the Advancement of Science (AAAS) has published a quarterly Professional Ethics Report since 1988, with scores of reports in each issue on events relevant to scientific ethics. AAAS has also announced a Demonstration Project on Providing Independent Experts to the Federal Courts and is cosponsoring, with the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies